Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (91-100 of 775) with videos related to

Pageof 78
Sort By:
Innere Medizin (Heidelberg, Germany)|December 18, 2025
[Chronic inflammatory bowel diseases : What contribution can endoscopy make?]Timo Rath, Markus F Neurath
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
New agents for immunosuppressionAndré Jefremow, Markus F Neurath
Abdominal Imaging|April 6, 2012
Insight into Crohn's disease pathomorphologyJonas Mudter, Markus F Neurath
Endoscopy|March 21, 2014
Colonoscopy, inflammatory bowel diseaseHelmut Neumann, Markus F Neurath
Expert Opinion on Biological Therapy|January 31, 2017
Top-down approach to biological therapy of Crohn's diseaseSimon Hirschmann, Markus F Neurath
Current Opinion in Molecular Therapeutics|November 7, 2003
Inflammatory bowel disorders: gene therapy solutionsStefan Wirtz, Markus F Neurath
Journal of Crohn'S & Colitis|March 7, 2021
Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?Raja Atreya, Markus F Neurath
Visceral Medicine|March 11, 2021
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic ImplicationsAndré Jefremow, Markus F Neurath
Innere Medizin (Heidelberg, Germany)|January 20, 2025
[Update on the pathophysiology, prediction and prevention of inflammatory bowel diseases]Sarah Fischer, Markus F Neurath
Journal of Crohn'S & Colitis|May 13, 2022
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical RealityRaja Atreya, Markus F Neurath
Pageof 78

Showing results (91-100 of 775) with videos related to

Sort By:
Pageof 78
Innere Medizin (Heidelberg, Germany)|December 18, 2025
[Chronic inflammatory bowel diseases : What contribution can endoscopy make?]Timo Rath, Markus F Neurath
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
New agents for immunosuppressionAndré Jefremow, Markus F Neurath
Abdominal Imaging|April 6, 2012
Insight into Crohn's disease pathomorphologyJonas Mudter, Markus F Neurath
Endoscopy|March 21, 2014
Colonoscopy, inflammatory bowel diseaseHelmut Neumann, Markus F Neurath
Expert Opinion on Biological Therapy|January 31, 2017
Top-down approach to biological therapy of Crohn's diseaseSimon Hirschmann, Markus F Neurath
Current Opinion in Molecular Therapeutics|November 7, 2003
Inflammatory bowel disorders: gene therapy solutionsStefan Wirtz, Markus F Neurath
Journal of Crohn'S & Colitis|March 7, 2021
Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?Raja Atreya, Markus F Neurath
Visceral Medicine|March 11, 2021
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic ImplicationsAndré Jefremow, Markus F Neurath
Innere Medizin (Heidelberg, Germany)|January 20, 2025
[Update on the pathophysiology, prediction and prevention of inflammatory bowel diseases]Sarah Fischer, Markus F Neurath
Journal of Crohn'S & Colitis|May 13, 2022
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical RealityRaja Atreya, Markus F Neurath
Pageof 78